Daily FNArena News

While some investors may be getting nervous about the outlook for commodity prices Barclays Capital notes structured products and those targeting new markets in the sector are growing in popularity.

Chartists at Barclays Capital expect gold to break through resistance at around US$950 per ounce in coming weeks but National Bank suggests this rally may be the peak for the metal.

This small company is exploiting its talent for creating innovative technologies for use in the global mining and metals industries.

Macquarie Countrywide has won a reprieve from its lenders, but is the shattered REIT now offering value?

Further weak economic data suggest the Australian economy is close to contracting, with Stephen Koukoulas at TD Securities seeing scope for a rate cutting cycle to begin before the end of the year.

Weekly musings by your editor. What is going to trigger a bounce in the Australian share market?

Australia’s retail sales numbers for May were far stronger than the market had expected, leading economist to question whether or not the RBA will feel the need to move again on rates.

Life science stocks are not exactly investor favourites at present but ABN Amro Morgans sees Acrux as a standout in the sector given its technology and solid financial position.

The Fed is banking on US inflation eventually falling due to economic weakness, but Morgan Stanley warns it may take longer than hoped. There are also implications for Australia.

The RBA has clearly become more concerned about inflation, but still anticipates a fall ahead.